Australian Cardiology Practice Review Issue 32, with commentary by A/Prof John Amerena

In this issue we feature:

–  2023 ESC guidelines for managing endocarditis
–  2023 ESC guidelines for ACS
–  Guideline for diagnosing and managing AF
–  Expert consensus statement on cardiac catheterisation for CHD
–  Urgent ECMO after cardiogenic shock admission could lower mortality
–  Increasing lipids with risk of worsening cardiac damage in adolescents
–  New warnings of romosozumab (Evenity) CV risks
–  ESC guidelines and documents planned for 2024
–  Real-world incidence of severe QT prolongation in patients taking antipsychotic drugs
–  Chronic hypertension and the risk of readmission for postpartum CV complications
–  Utility of smartwatches for identifying arrhythmias in children
–  COVID-19 resources
–  Conferences, workshops and CPD

Download the pdf here

The Australian National Standards of Care for Childhood-Onset Heart Disease (CoHD)

Announced by the Federal Health Minister last week and published in the Heart, Lung and Circulation, The Australian National Standards of Care for Childhood-Onset Heart Disease can be viewed see full text link below.

https://www.heartlungcirc.org/article/S1443-9506(23)04355-X/fulltext
Further to this read commentary below in an editorial by Prof David Celermajer.

National Standards of Care for Childhood onset Heart Disease (CoHD)—A New Paradigm Whereby Healthcare Professionals, Governments and Consumers Work Together to Optimise Patient Care. https://doi.org/10.1016/j.hlc.2024.01.015

CSANZ Members recently honoured by the Governor-General of Australia

Congratulations to the following CSANZ members who were recently awarded Honours by the Australian Governor-General for their service to medicine.

Prof Sally Lewers Dunwoodie AO
For distinguished service to medical research as an embryologist and geneticist, particularly in the field of foetal, and neonatal heart disease.
Victor Chang Cardiac Research Institute.

Dr Alan Lansell Soward OAM.   (Image courtesy: Ben Gross, Sunraysa Daily, Mildura)
For service to cardiology.
Founding cardiologist for Mildura Cardiology, and Adjunct Associate Professor at the School of Rural Health Mildura at Monash University, VIC.

REGISTER NOW | International Clinical Cardiovascular Genetics Conference (ICCG) | 8-10 MAY 2024

The ICCG 2024 always provides a fantastic learning experience, bringing together a vast multidisciplinary audience, including cardiologists, geneticists, nurses, genetic counsellors, and researchers. It is also a great meeting for students, early career researchers, trainees, fellows etc.

A key theme of this year’s meeting is the rapidly growing impact of genetics in cardiology practice, resulting in more precise diagnosis, guiding therapies, informing prognosis, screening families, and influencing reproduction decisions.

Read more about the international and national faculty here

 

Check out the full program on the website – talk topics include but not limited to:
• Inherited cardiomyopathies: what’s new?
• New Australian initiatives in familial hypercholesterolaemia
• Cardiovascular genomics in 2024
• Intersection of imaging and genetics in cardiomyopathies
• Utility of genetic testing – across the lifespan
• Genomics and therapeutics – the time is now
• Plus The Great Debate! Patients should (only) be seen in a specialised multidisciplinary clinic.
Are you For or Against? LISTEN AND LEARN as the experts battle it out!

 

SUBMIT YOUR ABSTRACT:
Abstracts may include: instructive case reports, development of methods, establishments of cohorts or registries, and abstracts presenting preliminary data

Read more about abstract submission here.              Abstracts close:  Wednesday, 28 February 2024.

Register NOW!     NB: Early bird registration closes: 11 Mar 2024

To be held at the Brisbane Convention Centre 8 – 10 May 2024

Follow #ICCG 2024

Abstracts are open for the NZ CSANZ ASM

The CSANZ New Zealand Annual Scientific Meeting 2024 to be held Ōtautahi Christchurch, from Thursday 13 June to Saturday 15 June 2024.

Planning is under way for a comprehensive program, with working group workshops, Nurses symposium and Registrar meeting on Thursday, and the Scientific Meeting opens on Friday 14th June

Read more about the International keynote speakers here

Abstracts can be submitted until 20:00 4 March 2024 (NZDT)  under the following themes:

Congenital / Genetics / Paediatrics / Pulmonary, Coronary Artery Disease, Heart Failure, Electrophysiology, Imaging
Structural and Valve Disease, Rehabilitation/Prevention, Nursing and Translational Research

Registration is now open – early bird discounts closing on 15 April 2024.

Cardiology Research Review Issue 161, with commentary by A/Prof John Amerena

In this edition:

–  Safety and tolerability of inclisiran in patients with hypercholesterolaemia
–  Intravascular imaging, functional, or angiographically guided coronary intervention
–  Educational attainment and lifetime risk of cardiovascular disease
–  Impact of bempedoic acid on cardiovascular events
–  Five-year follow-up after TAVI in low-risk patients
–  Effect of dietary sodium on blood pressure
–  Long-term outcomes of resynchronisation–defibrillation for heart failure
–  Risk of severe QT prolongation with quetiapine and haloperidol
–  Use of artificial intelligence to predict AF
–  No increased risk of suicidal ideation with semaglutide

Download the Cardiology Research Review Issue 161, with commentary by A/Prof John Amerena

2025 ANZET-UK Fellowships

Position: 2025 ANZET-UK Fellowships
Applications are invited for two prestigious one-year Fellowships at Leeds General Infirmary, UK:
• ANZET-UK Structural Fellowship
• ANZET-UK Intervention Fellowship
Leeds General Infirmary is a large tertiary cardiac centre in the United Kingdom, providing services to a population of 2.8 million in West Yorkshire, with supra-regional services to the broader population of Yorkshire & Humber, constituting 5.8 million.
The Fellowships are open to all Australian and New Zealand interventional trainees.
The proposed start date of the Fellowships is February 2025, although some flexibility depending on the preference of the successful candidate is possible.
1. ANZET-UK STRUCTURAL FELLOWSHIP
The trans-catheter valve programme in Leeds is led by Professor Dan Blackman ([email protected]), working with fellow interventional cardiologists Dr Chris Malkin, Dr Mike Cunnington, and Dr Noman Ali, and echocardiologists Dr Dominik Schlosshan and Dr James O’Neill.
This Fellowship will be focussed on trans-catheter valve intervention, in particular trans-catheter aortic valve implantation (TAVI). Leeds performs over 500 TAVI procedures annually. Currently Evolut, SAPIEN 3, Navitor, JenaValve Trilogy, and MyVal Octacorvalves are used. TAVI procedures are performed under local anaesthetic. More than 95% of procedures are trans-femoral, with percutaneous axillary access the alternate access route of choice. Leeds has a strong record of innovation in TAVI, having been the first centre in the UK to use Lotus, undertaken the first-in-human Evolut study, the first-in-human Triguard cerebral embolic protection study, and been at the forefront of cerebral embolic protection and subclavian access. There is an active research programme supported by 5 research nurses, with multiple peer-reviewed publications in the field.
The Fellow would participate in all TAVI procedures, and would be trained in all aspects of TAVI. Amongst the 500+ cases in the 12-month post, the Fellow could expect to perform a minimum of 150 cases as 1st operator, and be able to function as an independent 1st operator at the end of the year’s programme.
Leeds has a growing mitral intervention programme. Transcatheter Edge to Edge Repair was started in 2018, and Leeds was approved in 2022 as the sole centre for the 5.8 million population of Yorkshire & Humber, with 40 procedures currently performed annually. Leeds has also been involved in trials of the Carillon and Millipede mitral annuloplasty devices, and trans-catheter mitral valve replacement (TMVR) with the Medtronic Intrepid and High-Life valves. We are currently recruiting to theAPOLLO-EU Intrepid trial. Mitral valvuloplasty is also performed, as are TAVI-in-Mitral valve and ring procedures. Tricuspid intervention has been performed with the Tricinch device, with tricuspid TEER due to start in 2024, alongside potential TTVR with Cardiovalve and/or Evoque.
The Fellow would be involved in all mitral and tricuspid procedures, and would gain experience in trans-septal puncture and mitral intervention.
Non-valve structural interventions, such as LAAO, PFO and ASD closure, are undertaken by a separate adult congenital intervention team in Leeds. Some exposure to these interventions may be available.
The Fellowship would also offer continued involvement in PCI, in order to maintain expertise. However, it will not offer full training in PCI to more junior trainees, since the focus is on structural intervention. Currently 2300 PCIs are performed in Leeds annually, including 1100 primary PCIs.
In addition to clinical activity the Fellow would be expected to take an active part in the Leeds Trans-catheter Valve research programme, leading and contributing to studies that would result in presentation at international meetings and peer-reviewed publications.
Medtronic UK has agreed to support the funding of this Fellowship. The salary is expected to be approximately £58,000 (UK Sterling), which is the basic pay of a Final Year trainee in the UK. Additional income through voluntary out-of-hours on-call will be available, provided it does not impact on the work of the Fellow.
Eligibility
The ANZET-UK Structural Fellowship is intended for a senior interventional cardiology trainee who has already obtained extensive training in percutaneous coronary intervention and who wishes to pursue a sub-specialist interest in valve intervention.
2. ANZET-UK INTERVENTION FELLOWSHIP
Leeds is a high-volume centre performing 2300 PCI per annum, of which 1100 are primary PCI maintaining the centre’s status as busiest PPCI centre in the UK. The PCI team is led by Dr Jennifer Rossington ([email protected]), working with Dr Murugu Veerasamy,Dr Abdul Mozid,Dr Heeraj Bulluck and Dr Jonathan Blaxill. There are a further 5 interventionalists involved in the acute service with specialist interest in structural intervention or research and 11 visiting consultants supporting out of hours working. The department has an excellent complex programme with frequent left main stem, bifurcation, calcified lesion and chronic total occlusion PCI; which the Fellow would be expected to gain first operator experience. 120-150 CTO cases are performed per annum with a 95% success rate utilising all advanced techniques (AEW, retrograde, ADR). During fellowship there will be frequent exposure to complex PCI equipment including for lesion modification (Rotablation, Orbital, Shockwave, Laser) and intravascular imaging (IVUS, OCT).
The Fellow is expected to fully participate in the PCI programme with commitments to complete patient management, meetings, research and conferences. Complete patient care requires pre-procedural planning, patient discussions and post procedure care. Weekly coronary interventional meetings and revascularisation MDT are to be attended. There is an active research programme facilitated by research nurses, with continuous recruitment to local, national and international trials requiring on-going support from the medical staff. At Leeds there is an established regional and national meetings for complex intervention.The Fellow would be anticipated to present and have active involvement in live cases.
This annual PCI Fellowship is designed to provide the skills required to be an independent PCI operator with high levels of exposure to ACS invasive management and complex PCI.
The post is funded by Leeds Teaching Hospitals NHS Trust and the expected salary is dependent on level of experience but is expected to be approximately £58,000. Additional income through voluntary out-of-hours on-call will be available, provided it does not impact on the work as a Fellow.
Eligibility
Applicants for the ANZET-UK Intervention Fellowship should have completed advanced training in cardiology and hold FRACP, be fully competent in radial access coronary angiography and preferably have basic proficiency in coronary intervention.
APPOINTMENT PROCESS FOR BOTH POSITIONS
There will be a competitive appointment process co-ordinated by A/Prof Ajay Sinhal at Flinders Medical Centre, Adelaide. The Interview panel will include senior interventional cardiologists from Australian and New Zealand centres.
HOW TO APPLY
To apply for the ANZET-UK Fellowships please provide:
• a copy of your CV
• letters of support from two supervisory consultants
Applications should be addressed to A/Prof Ajay Sinhal and emailed to: [email protected]
FURTHER INFORMATION
If you have any questions regarding the Fellowships, please email A/Prof Sinhal: [email protected]
The deadline for applications is Friday, 23 February, 2024

2025 CSANZ-UK Interventional Fellowship

Position: 2025 CSANZ-UK Interventional Fellowship
Applications are invited for a funded 12-month advanced PCI fellowship programme at Wythenshawe University Hospital, South Manchester NHS trust.
This position offers the opportunity to gain high volume experience in complex interventional cardiology, with a focus on intracoronary imaging and calcium modification, in a busy university teaching hospital. There is also a busy structural heart disease program (TAVI and MTEER) and the opportunity to gain international experience in a different healthcare system.
The Fellowship is intended for a senior cardiology trainee who holds FRACP and who wishes to pursue a career in interventional cardiology. It is a 12-month Fellowship with a proposed start date of February 2025.
Job description
Wythenshawe Hospital provides tertiary cardiac services to the South Manchester and North Cheshire area and is supported by on-site Cardiothoracic surgery and an active cardiac transplant unit. This is a senior training position covering all aspects of complex coronary intervention such as rotational atherectomy, true bifurcation cases and CTO angioplasty including antegrade dissection re-entry and retrograde techniques.
The program delivers around 1500 PCIs/yr and 200 TAVIs/yr and the unit has 6 Cardiac Catheter Laboratories. The Fellow works with a team of 8 in-house interventional cardiologists who perform a wide range of acute and complex elective PCI including 24/7 primary PCI for a population of 3.2 million. The department is particularly active in intracoronary imaging using IVUS and OCT, hosting the largest national annual training meeting in the UK. There is an active structural program including PFO closure, a mature TAVI program, and a percutaneous mitral valve clip program. The interventional programme is supported by a comprehensive imaging service including stress echocardiography as well as dedicated cardiac MRI and CT (including CT coronary angiography).
The department is active in interventional research with a strong record of recruitment into international trials as well as developing in house research protocols covering IVUS, OCT, FFR and Cardiac MRI.
Eligibility and Appointment Process
Eligible applicants should have completed advanced training in cardiology and hold FRACP, be fully competent in radial access coronary angiography and preferably have basic proficiency in coronary intervention.
There will be a competitive appointment process, coordinated by A/Prof Ajay Sinhal at Flinders Medical Centre, Adelaide. The interview panel will include senior interventional cardiologists from Australian and New Zealand centres.
How to Apply
To apply for this opportunity, please send your CV with letters of support from two supervisory consultants to the attention of A/Prof Sinhal email: i[email protected] 
The deadline for applications is Friday, 23 February 2024

Australasian Cardiac Outcomes Registry (ACOR) | 2024 UPDATE

ACOR is looking forward to a big year ahead!

The execution of the Australian Transcatheter Valves Therapy Registry (ATVT) Agreement with SAHMRI will see the TAVI Registry converge from a singular Registry into a four-valve Registry. This has been over a year in the making, and we are very excited to see the projects and opportunities that come from the creation of this new Registry, including new databases that incorporate the mitral, pulmonary and tricuspid heart valves.

Currently, there are 52 TAVI sites, with two more onboarding and 17,685 cases (as of 23/10/2023) entered into the Registry since commencement (April 2018).

ACOR continues to seek funding opportunities and looks forward to an exciting year ahead.

Read more about the Australasian Cardiac Outcomes Registry at acor.net.au

Alana Carpenter, Project Officer for ACOR (above left) is about to have her first baby and will be on maternity leave from Friday, 23 February 2024. We wish Alana and her husband Scott well and look forward to seeing baby photos soon!

We are delighted to welcome Jessica Casley (above right), as the interim ACOR Project Officer.  Jessica comes from an administration background and has a Bachelor of Science (Physiology) from Monash University. Jessica previously worked at Cabrini Health and the University of Melbourne. She brings with her strong experience in project co-ordination and administrative support, as well as a passion for health and scientific research.

VALE | Dr David Hunt, MBBS, FRACP, FCSANZ, DDU, FACC

It is with deep regret that we note the passing of Dr David Hunt, MBBS, FRACP, FCSANZ, DDU, FACC, who died at his home in Melbourne on Thursday 11 January 2024.  On behalf of the Cardiac Society Board and members, we would like to extend our sincere sympathies to his family and CSANZ colleagues.

Read in full here 

Image courtesy: Planning retirement from practice – Dr David Hunt discusses his career and retirement from his life long work on Youtube (RACP Channel) Dr Hunt’s own photo found in the CSANZ’s historical record of Cardiology of Australia and New Zealand, section 5.4 on the Royal Melbourne Hospital (contributors Dr David Hunt and Dr Alan Goble).

Posts navigation